In a pilot that included more than 350 chronic heart failure patients, a Philadelphia hospital was able to reduce its 30-day readmissions by 10 percent -- a 40 percent improvement over baseline -- by using email and text message reminders to get patients into follow-up appointments. Dr. Thompson Boyd, physician liaison at Hahnemann Hospital and Richard Imbimbo, the hospital's CFO, spoke at HIMSS...
At the America’s Health Insurance Plans (AHIP) Institute conference this week, Aetna and Intel released preliminary findings from their Intel Health Guide pilot for chronic heart failure (CHF) patients. The pilots aim was to demonstrate how remote patient monitoring and nurse case management could improve the health of Medicare patients with CHF.
Dr. Randall Krakauer, Aetna’s national Medicare...
CardioMEMS, the company developing a wireless implantable sensor for heart failure patients, has recently announced the results of its nearly three year-long CHAMPION trial. One of the topline results from the trial: The number of hospitalizations for heart failure patients reduced by 38 percent over the the full duration of the study.
CHAMPION stands for: CardioMEMS Heart Sensor Allows...
CardioMEMS, which develops wireless, implantable medical sensors, announced a new $37.9 million round of venture capital investment. That brings the company's total raised capital amount to about $145 million. Previous investors include Arcapita Ventures, Boston Millennia Partners, Medtronic, Easton Capital Partners, Foundation Medical Partners, Arboretum Ventures, Deerfield Capital Management,...
A study set to be published in the upcoming issue of the Journal of Medical Internet Research found that mobile phone-based telemonitoring of patients with chronic heart failure (CHF) has the potential to reduce frequency and duration of heart failure hospitalizations. The study also included a caveat that ensuring elderly patients, in particular, could use the mobile phone-based service's user...
